Hoth Therapeutics Expands Oncology Pipeline With Dual Patent Filings

Benzinga · 01/02 13:20

The first provisional patent application, titled covering the topical treatment of radiation-induced skin toxicity in oncology patients.

The second provisional patent application, titled addressing dermatologic toxicities associated with emerging targeted cancer therapies, including second and third menin inhibitors.